Comments
Loading...

Halozyme Therapeutics Informe de interés a corto plazo

HALONASDAQ
Logotipo presentado por Benzinga Data
$70.25
0.150.21%
al cierre: Nov 18, 4:00 PM EST
$69.90
-0.35-0.49%
Pre-comercialización: 8:24 AM EST
Elektrofi, Inc was acquired by Halozyme Therapeutics (HALO) on Tuesday, November 18, 2025 for $750.0M

Informe de interés en corto

El interés corto en Halozyme Therapeutics Inc (NASDAQ:HALO) ha disminuido durante el último período de informe, aumentando en descenso desde 11.51M hasta 11.31M. Esto representa el 13.49% de las acciones disponibles públicamente de la empresa.

Basado en el volumen promedio reciente de 1.48M acciones negociadas por día, tomaría 7.65 día(s) para que los poseedores de este interés corto cierren sus posiciones sin impulsar bruscamente el precio de las acciones.

Interés en corto
11.31M
Interés en corto %
13.5%
Días para cubrir
7.65
Get Alert
HALO
Halozyme Therapeutics, Inc. Co
10/31/2025
11/11/2025
13.49%
83,777,977
11,305,141
1,477,599
7.65
HALO
Halozyme Therapeutics, Inc. Co
10/15/2025
10/24/2025
13.74%
83,777,977
11,510,110
2,398,287
4.8
HALO
Halozyme Therapeutics, Inc. Co
09/30/2025
10/09/2025
12.89%
83,777,977
10,797,290
2,208,182
4.89
HALO
Halozyme Therapeutics, Inc. Co
09/15/2025
09/24/2025
14.06%
83,777,977
11,779,854
1,836,341
6.41
HALO
Halozyme Therapeutics, Inc. Co
08/29/2025
09/10/2025
14.18%
83,777,977
11,883,269
2,069,526
5.74
HALO
Halozyme Therapeutics, Inc. Co
08/15/2025
08/26/2025
12.62%
83,777,977
10,571,710
2,285,628
4.63
HALO
Halozyme Therapeutics, Inc. Co
07/31/2025
08/11/2025
11.86%
83,777,977
9,932,500
1,249,951
7.95
HALO
Halozyme Therapeutics, Inc. Co
07/15/2025
07/24/2025
10.67%
90,032,977
9,602,474
1,558,889
6.16
HALO
Halozyme Therapeutics, Inc. Co
06/30/2025
07/10/2025
11.30%
90,032,977
10,176,028
4,223,614
2.41
HALO
Halozyme Therapeutics, Inc. Co
06/13/2025
06/25/2025
12.29%
90,032,977
11,065,499
1,648,108
6.71
HALO
Halozyme Therapeutics, Inc. Co
05/30/2025
06/10/2025
11.72%
90,032,977
10,551,963
2,027,055
5.21
HALO
Halozyme Therapeutics, Inc. Co
05/15/2025
05/27/2025
11.87%
90,032,977
10,690,600
4,533,203
2.36
HALO
Halozyme Therapeutics, Inc. Co
04/30/2025
05/09/2025
10.51%
90,032,977
9,462,038
1,291,786
7.32
HALO
Halozyme Therapeutics, Inc. Co
04/15/2025
04/25/2025
10.65%
90,345,287
9,619,716
1,800,888
5.34
HALO
Halozyme Therapeutics, Inc. Co
03/31/2025
04/09/2025
10.21%
90,345,287
9,221,727
1,682,855
5.48
HALO
Halozyme Therapeutics, Inc. Co
03/14/2025
03/25/2025
11.15%
90,345,287
10,069,735
1,455,005
6.92
HALO
Halozyme Therapeutics, Inc. Co
02/28/2025
03/11/2025
10.83%
89,982,739
9,748,013
1,365,287
7.14
HALO
Halozyme Therapeutics, Inc. Co
02/14/2025
02/26/2025
10.25%
89,982,739
9,221,430
977,109
9.44
HALO
Halozyme Therapeutics, Inc. Co
01/31/2025
02/11/2025
9.63%
94,056,739
9,055,762
1,072,280
8.45
HALO
Halozyme Therapeutics, Inc. Co
01/15/2025
01/27/2025
10.00%
94,056,739
9,405,294
1,757,468
5.35
HALO
Halozyme Therapeutics, Inc. Co
12/31/2024
01/10/2025
10.16%
93,508,019
9,504,876
1,532,701
6.2
HALO
Halozyme Therapeutics, Inc. Co
12/13/2024
12/24/2024
9.40%
93,508,019
8,789,545
1,016,508
8.65
HALO
Halozyme Therapeutics, Inc. Co
11/29/2024
12/10/2024
9.16%
93,508,019
8,566,431
2,558,102
3.35
HALO
Halozyme Therapeutics, Inc. Co
11/15/2024
11/26/2024
11.18%
93,508,019
10,450,111
2,203,379
4.74
HALO
Halozyme Therapeutics, Inc. Co
10/31/2024
11/11/2024
10.96%
93,508,019
10,249,324
1,028,448
9.97
HALO
Halozyme Therapeutics, Inc. Co
10/15/2024
10/24/2024
11.14%
93,508,019
10,416,746
1,641,838
6.34
HALO
Halozyme Therapeutics, Inc. Co
09/30/2024
10/09/2024
10.54%
93,508,019
9,854,920
1,484,928
6.64
HALO
Halozyme Therapeutics, Inc. Co
09/13/2024
09/24/2024
10.30%
93,508,019
9,635,995
1,102,235
8.74
HALO
Halozyme Therapeutics, Inc. Co
08/30/2024
09/11/2024
10.74%
93,508,019
10,040,022
1,296,147
7.75
HALO
Halozyme Therapeutics, Inc. Co
08/15/2024
08/26/2024
10.35%
93,508,019
9,673,467
1,341,528
7.21
HALO
Halozyme Therapeutics, Inc. Co
07/31/2024
08/09/2024
9.57%
93,508,019
8,945,252
1,122,076
7.97
HALO
Halozyme Therapeutics, Inc. Co
07/15/2024
07/24/2024
9.25%
94,103,739
8,708,189
1,302,955
6.68
HALO
Halozyme Therapeutics, Inc. Co
06/28/2024
07/10/2024
9.59%
94,103,739
9,024,638
1,487,993
6.06
HALO
Halozyme Therapeutics, Inc. Co
06/14/2024
06/26/2024
9.89%
94,103,739
9,308,538
1,684,971
5.52
HALO
Halozyme Therapeutics, Inc. Co
05/31/2024
06/11/2024
9.10%
94,103,739
8,562,180
966,154
8.86
HALO
Halozyme Therapeutics, Inc. Co
05/15/2024
05/24/2024
9.10%
94,103,739
8,558,777
1,157,005
7.4
HALO
Halozyme Therapeutics, Inc. Co
04/30/2024
05/09/2024
8.93%
94,103,739
8,406,488
719,397
11.69
HALO
Halozyme Therapeutics, Inc. Co
04/15/2024
04/24/2024
8.78%
93,883,979
8,238,441
980,032
8.41
HALO
Halozyme Therapeutics, Inc. Co
03/28/2024
04/09/2024
8.40%
93,883,979
7,885,978
772,456
10.21
HALO
Halozyme Therapeutics, Inc. Co
03/15/2024
03/26/2024
8.74%
93,883,979
8,201,639
1,083,698
7.57
HALO
Halozyme Therapeutics, Inc. Co
02/29/2024
03/11/2024
8.61%
93,883,979
8,082,695
1,409,031
5.74
HALO
Halozyme Therapeutics, Inc. Co
02/15/2024
02/27/2024
7.19%
106,408,913
7,647,117
1,035,888
7.38
HALO
Halozyme Therapeutics, Inc. Co
01/31/2024
02/09/2024
6.84%
111,682,223
7,637,269
1,820,412
4.2
HALO
Halozyme Therapeutics, Inc. Co
01/12/2024
01/24/2024
6.42%
111,682,223
7,165,717
1,813,213
3.95
HALO
Halozyme Therapeutics, Inc. Co
12/29/2023
01/10/2024
6.58%
111,682,223
7,349,534
1,140,204
6.45
HALO
Halozyme Therapeutics, Inc. Co
12/15/2023
12/27/2023
6.71%
111,682,223
7,499,289
983,474
7.63
HALO
Halozyme Therapeutics, Inc. Co
11/30/2023
12/11/2023
6.38%
111,682,223
7,126,171
832,547
8.56
HALO
Halozyme Therapeutics, Inc. Co
11/15/2023
11/27/2023
6.24%
111,682,223
6,974,433
1,290,654
5.4